Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $8.1 Trillion
- Q1 2025
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 3,055,228 shares of AZN stock, worth $211 Million. This represents 2.77% of its overall portfolio holdings.
Number of Shares
3,055,228
Previous 3,745,531
18.43%
Holding current value
$211 Million
Previous $245 Billion
8.5%
% of portfolio
2.77%
Previous 2.8%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,402Shares Held
504MCall Options Held
6.05MPut Options Held
4.05M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.16 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.8 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.46 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.16 Billion0.47% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.66 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...